{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:53Z","timestamp":1781643473267,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F31CA295016"],"award-info":[{"award-number":["F31CA295016"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1F31HD117697-01A1"],"award-info":[{"award-number":["1F31HD117697-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We conducted a scoping review of research on vascular function (VF) in colorectal cancer (CRC) survivors and developed a research agenda to address current limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Scoping Review (PRISMA-ScR) when conducting and reporting this review. We searched 3 databases (PubMed, EBSCOhost, and EMBASE) in October 2025 for publications on VF and vascular dysfunction (VD) that included measures of arterial stiffness and endothelial function in CRC survivors. There were 348 manuscripts identified for title and abstract screening, and 341 were excluded for not meeting the inclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our search and subsequent screening identified seven papers reporting measures of VF in CRC survivors. Five papers focused on the impact of systemic therapies on measures of VF, including PWV and FMD, whereas two papers examined the effect of colon surgery on surrogate measures of VF. Increased arterial stiffness and atherosclerosis were observed following systemic treatment; however, endothelial function was inconsistent. Following colon surgery, endothelial function declined, while arterial stiffness remained unchanged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CRC survivors who underwent systemic treatment had increased arterial stiffness and atherosclerosis, and those who underwent colon surgery had endothelial dysfunction. Overall, there is limited research on VF in CRC survivors, and we outline an agenda for future research to investigate VF in this population and address the numerous gaps in the field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors:<\/jats:title>\n                    <jats:p>This review highlights that CRC survivors may experience vascular health risks following systemic therapy and colon surgery, emphasizing the need for improved VF monitoring and survivorship care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12029-026-01438-6","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:25:49Z","timestamp":1774081549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular Dysfunction in Colorectal Cancer: Scoping Review of Current Evidence for Guiding Future Research"],"prefix":"10.1007","volume":"57","author":[{"given":"Sydney R.","family":"DeJonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah G.","family":"DuBose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Gantt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tussing-Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Motl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"1","key":"1438_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.6004\/jnccn.2009.0058","volume":"7","author":"CS Denlinger","year":"2009","unstructured":"Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw. 2009;7(8):883\u201393. quiz 94.","journal-title":"J Natl Compr Canc Netw"},{"key":"1438_CR3","doi-asserted-by":"publisher","first-page":"e41999","DOI":"10.2196\/41999","volume":"9","author":"H Qiu","year":"2023","unstructured":"Qiu H, Wang L, Zhou L, Wang X. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study. JMIR Public Health Surveill. 2023;9:e41999.","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"1438_CR4","first-page":"627","volume":"85","author":"M Khan","year":"2025","unstructured":"Khan M, Ayaz A. CARDIOVASCULAR (CV) MORTALITY IN ADULTS DIAGNOSED WITH COLORECTAL CANCER (CRC): A RETROSPECTIVE COHORT STUDY. JAAC. 2025;85(12):627.","journal-title":"JAAC"},{"key":"1438_CR5","doi-asserted-by":"crossref","unstructured":"Choksey A, Timm KN. Cancer Therapy-Induced Cardiotoxicity-A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy. Int J Mol Sci. 2021;23(1):441.","DOI":"10.3390\/ijms23010441"},{"issue":"14","key":"1438_CR6","doi-asserted-by":"publisher","first-page":"e015598","DOI":"10.1161\/JAHA.119.015598","volume":"9","author":"SK Parr","year":"2020","unstructured":"Parr SK, Liang J, Schadler KL, Gilchrist SC, Steele CC, Ade CJ. Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2020;9(14):e015598.","journal-title":"J Am Heart Assoc"},{"key":"1438_CR7","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.pharmthera.2022.108116","volume":"237","author":"JD Terwoord","year":"2022","unstructured":"Terwoord JD, Beyer AM, Gutterman DD. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther. 2022;237:108116.","journal-title":"Pharmacol Ther"},{"key":"1438_CR8","doi-asserted-by":"crossref","unstructured":"Kashyap MK, Mangrulkar SV, Kushwaha S, Ved A, Kale MB, Wankhede NL et al. Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy. Pharmaceuticals (Basel). 2023;16(10):1441.","DOI":"10.3390\/ph16101441"},{"issue":"9","key":"1438_CR9","doi-asserted-by":"publisher","first-page":"95001","DOI":"10.1289\/EHP9321","volume":"129","author":"L Lind","year":"2021","unstructured":"Lind L, Araujo JA, Barchowsky A, Belcher S, Berridge BR, Chiamvimonvat N, et al. Key Characteristics of Cardiovascular Toxicants. Environ Health Perspect. 2021;129(9):95001.","journal-title":"Environ Health Perspect"},{"key":"1438_CR10","doi-asserted-by":"publisher","first-page":"111712","DOI":"10.1016\/j.jclinepi.2025.111712","volume":"181","author":"H Khalil","year":"2025","unstructured":"Khalil H, Jia R, Moraes EB, Munn Z, Alexander L, Peters MDJ, et al. Scoping reviews and their role in identifying research priorities. J Clin Epidemiol. 2025;181:111712.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1438_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/wvn.12144","volume":"13","author":"H Khalil","year":"2016","unstructured":"Khalil H, Peters M, Godfrey CM, McInerney P, Soares CB, Parker D. An Evidence-Based Approach to Scoping Reviews. Worldviews Evid Based Nurs. 2016;13(2):118\u201323.","journal-title":"Worldviews Evid Based Nurs"},{"issue":"7","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"30","key":"1438_CR13","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil A, Holder SM, Faita F, Greyling A, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534\u201347.","journal-title":"Eur Heart J"},{"issue":"1","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","volume":"168","author":"RT Ras","year":"2013","unstructured":"Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168(1):344\u201351.","journal-title":"Int J Cardiol"},{"issue":"19","key":"1438_CR15","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","volume":"31","author":"Reference Values for Arterial Stiffness C","year":"2010","unstructured":"Reference Values for Arterial Stiffness C. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u2018establishing normal and reference values\u2019. Eur Heart J. 2010;31(19):2338\u201350.","journal-title":"Eur Heart J"},{"issue":"Pt 11","key":"1438_CR16","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awr253","volume":"134","author":"GF Mitchell","year":"2011","unstructured":"Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene\/Environment Susceptibility\u2013Reykjavik study. Brain. 2011;134(Pt 11):3398\u2013407.","journal-title":"Brain"},{"issue":"5","key":"1438_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.105.555235","volume":"113","author":"FU Mattace-Raso","year":"2006","unstructured":"Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657\u201363.","journal-title":"Circulation"},{"issue":"5","key":"1438_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/annonc\/mdp417","volume":"21","author":"N Steeghs","year":"2010","unstructured":"Steeghs N, Rabelink TJ, op \u2018t Roodt J, Batman E, Cluitmans FH, Weijl NI, et al. Reversibility of capillary density after discontinuation of bevacizumab treatment. Ann Oncol. 2010;21(5):1100\u20135.","journal-title":"Ann Oncol"},{"issue":"2","key":"1438_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3892\/ol.2015.4017","volume":"11","author":"H Studentova","year":"2016","unstructured":"Studentova H, Indrakova J, Petrova P, Kaminek M, Kalabova H, Sramek V, et al. Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor. Oncol Lett. 2016;11(2):939\u201344.","journal-title":"Oncol Lett"},{"key":"1438_CR20","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.2147\/OTT.S156318","volume":"11","author":"E Res","year":"2018","unstructured":"Res E, Kyvelou SM, Vlachopoulos C, Manousou K, Tousoulis D, Stefanadis C, et al. Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy. Onco Targets Ther. 2018;11:6785\u201393.","journal-title":"Onco Targets Ther"},{"issue":"12","key":"1438_CR21","doi-asserted-by":"publisher","first-page":"e1956","DOI":"10.1634\/theoncologist.2020-0225","volume":"25","author":"RV Groehs","year":"2020","unstructured":"Groehs RV, Negrao MV, Hajjar LA, Jordao CP, Carvalho BP, Toschi-Dias E, et al. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer. Oncologist. 2020;25(12):e1956\u201367.","journal-title":"Oncologist"},{"issue":"6","key":"1438_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.0306-5251.2001.01495.x","volume":"52","author":"IBWD Wilkinson","year":"2001","unstructured":"Wilkinson IBWD. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol. 2001;52(6):631\u201346.","journal-title":"Br J Clin Pharmacol"},{"key":"1438_CR23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/CMAR.S223032","volume":"12","author":"A Visvikis","year":"2020","unstructured":"Visvikis A, Kyvelou SM, Pietri P, Georgakopoulos C, Manousou K, Tousoulis D, et al. Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer. Cancer Manag Res. 2020;12:1175\u201385.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"1438_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/bja\/aew410","volume":"118","author":"S Ekeloef","year":"2017","unstructured":"Ekeloef S, Larsen MH, Schou-Pedersen AM, Lykkesfeldt J, Rosenberg J, Gogenur I. Endothelial dysfunction in the early postoperative period after major colon cancer surgery. Br J Anaesth. 2017;118(2):200\u20136.","journal-title":"Br J Anaesth"},{"key":"1438_CR25","doi-asserted-by":"crossref","unstructured":"Chuang CYCT, Li DK, Chiu CM, Fang CW, Ng HP, Huang CM, Chen JJ. Colectomy influences the radial pulse parameters of traditional Chinese medicine pulse diagnosis in patients with colorectal cancer. Eur J Integr Med. 2020;35:101067.","DOI":"10.1016\/j.eujim.2020.101067"},{"issue":"24","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.jacc.2021.06.017","volume":"78","author":"MO Ogunniyi","year":"2021","unstructured":"Ogunniyi MO, Commodore-Mensah Y, Ferdinand KC, Race. Ethnicity, Hypertension, and Heart Disease: JACC Focus Seminar 1\/9. J Am Coll Cardiol. 2021;78(24):2460\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1438_CR27","doi-asserted-by":"publisher","first-page":"e007917","DOI":"10.1161\/CIRCOUTCOMES.121.007917","volume":"15","author":"Z Javed","year":"2022","unstructured":"Javed Z, Haisum Maqsood M, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, et al. Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial\/Ethnic Disparities in Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2022;15(1):e007917.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1438_CR28","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.pmedr.2020.101263","volume":"21","author":"S Sakhuja","year":"2021","unstructured":"Sakhuja S, Fowler ME, Ojesina AI. Race\/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease. Prev Med Rep. 2021;21:101263.","journal-title":"Prev Med Rep"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01438-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01438-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:37:24Z","timestamp":1781642244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01438-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01438-6","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}